ロード中...
The role of B cells in multiple sclerosis: current and future therapies
While it was long held that T cells were the primary mediators of multiple sclerosis (MS) pathogenesis, the beneficial effects observed in response to treatment with Rituximab, a monoclonal antibody (mAb) targeting CD20, shed light on a key contributor to MS that had been previously underappreciated...
保存先:
| 出版年: | Cell Immunol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540809/ https://ncbi.nlm.nih.gov/pubmed/31130183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2018.10.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|